Effects of nebulised iloprost on pulmonary function and oxygenation in patients with severe pulmonary hypertension Source: Eur Respir J 2002; 20: Suppl. 38, 370s Year: 2002
Long-term bosentan therapy improves exercise capacity and hemodynamics in sarcoidosis-associated pulmonary hypertension Source: Annual Congress 2012 - Pulmonary circulation: clinical PAH, registries and treatments Year: 2012
Effects of NO inhalation on porcine cerebral haemodynamics and oxygenation Source: Eur Respir J 2001; 18: Suppl. 33, 238s Year: 2001
Long-term treatment with oral sildenafil in addition to chronic prostacyclin therapy improves pulmonary hemodynamics and six minute walking test in patients with pulmonary arterial hypertension Source: Eur Respir J 2002; 20: Suppl. 38, 598s Year: 2002
Inhaled iloprost improves hemodynamics at exercise in primary and secondary precapillary pulmonary hypertension Source: Eur Respir J 2002; 20: Suppl. 38, 597s Year: 2002
Efficacy of epoprostenol treatment for pulmonary hypertension: hemodynamic and clinical improvement during the initial 8-month period Source: Eur Respir J 2001; 18: Suppl. 33, 325s Year: 2001
Effect of intravenous epoprostenol on quality of life in pulmonary arterial hypertension Source: Eur Respir J 2003; 22: Suppl. 45, 563s Year: 2003
Long-term improvement of pulmonary haemodynamics and exercise capacity in patients with pulmonary hypertension and hypoventilation following NIPPV and influence of NIPPV adherence Source: International Congress 2015 – Pulmonary hypertension in lung disease Year: 2015
Intravenous iloprost for pulmonary arterial hypertension: still waiting for evidence Source: Eur Respir J 2009; 34: 7-9 Year: 2009
“Treat-to-target” in pulmonary arterial hypertension and the use of extracorporeal membrane oxygenation as a bridge to transplantation Source: Eur Respir Rev 2011; 20: 297-300 Year: 2011
Use of noninvasive ventilation in the early postoperative period of lung transplantation Source: Annual Congress 2012 - Optimising outcomes after lung transplantation Year: 2012
Impact of long-term oxygen therapy on diaphragm function and pulmonary-cardiac hemodynamics in patients with COPD with hypoxemia (3-year assessment) Source: International Congress 2019 – Lung function and respiratory muscle testing Year: 2019
The effect of iloprost on arterial oxygenation during one-lung ventilation Source: International Congress 2016 – Current challenges in thoracic surgery Year: 2016
Consistency of the acute hemodynamic response to inhaled iloprost in pulmonary hypertension patients treated long-term with iloprost aerosol Source: Eur Respir J 2001; 18: Suppl. 33, 323s Year: 2001
Long-term outcome with intravenous iloprost in pulmonary arterial hypertension Source: Eur Respir J 2009; 34: 132-137 Year: 2009
Intra-hospital physiotherapy programme effects in the pulmonary function and exercise capacity in patients during the early postoperative period of heart transplantation Source: Annual Congress 2009 - Treatment modalities in chest physiotherapy Year: 2009
Improved survival in pulmonary hypertension during pregnancy using vasodilator therapy and early elective delivery Source: Annual Congress 2007 - Pulmonary hypertension in the clinic Year: 2007
Hemodynamics effects of NPPV in cardiogenic pulmonary edema Source: Eur Respir J 2006; 28: Suppl. 50, 820s Year: 2006
Long-term effects of bosentan on the heart and pulmonary hemodynamics in pulmonary arterial hypertension, a comparison study with epoprostenol Source: Annual Congress 2005 - Pulmonary arterial hypertension diagnosis and therapy Year: 2005
Successful use of thrombolytic therapy in the management of acute proximal pulmonary embolism without significant haemodynamic compromise Source: Eur Respir J 2005; 26: Suppl. 49, 272s Year: 2005